Scott Cotler
FCO Division Director, Hepatology
Hepatitis B
Hepatitis C
Other causes of chronic liver disease
Liver Cancer
Loyola Outpatient Center
Loyola Center for Health at Burr Ridge
Loyola Hepatology Clinic - Mercy Medical at Dearborn Station
Loyola Hepatology Clinic in Chinatown
Loyola Hepatology Clinic in Moline
Loyola Hepatology Clinic in Peoria
Loyola Hepatology Clinic in Rockford
Loyola Center for Health at Homer Glen
Board Certifications
Gastroenterology - Subspecialty Cert: AM Board of Internal Medicine
Internal Medicine - General Cert: AM Board of Internal Medicine
Transplant Hepatology - Subspecialty cert: AM Board of Internal Medicine
Malespin,M.; Sleesman,B.; Lau,A.; Wong,S. S.; Cotler,S. J.Prevalence and Correlates of Suspected Nonalcoholic Fatty Liver Disease in Chinese American Children Journal of clinical gastroenterology 2014 ; :
Shang,N.; Arteaga,M.; Zaidi,A.; Stauffer,J.; Cotler,S. J.; Zeleznik-Le,N.; Zhang,J.; Qiu,W.FAK is required for c-Met/beta-catenin-driven hepatocarcinogenesis Hepatology (Baltimore, Md.) 2014 ; :
Layden,J. E.; Tayo,B. O.; Cotler,S. J.; Clark,N. M.; Baraoidan,K.; Friedman,S. L.; Cooper,R. S.Association of Genetic Variants With Rapid Fibrosis: Progression After Liver Transplantation for Hepatitis C Transplantation 2014 ; :
Guedj,J.; Rotman,Y.; Cotler,S. J.; Koh,C.; Schmid,P.; Albrecht,J.; Haynes-Williams,V.; Liang,J. T.; Hoofnagle,J. H.; Heller,T.; Dahari,H.Understanding early serum hepatitis D virus and HBsAg kinetics during pegylated interferon-alfa therapy via mathematical modeling Hepatology (Baltimore, Md.) 2014 ; :
Casadaban,L.; Malespin,M.; Cheung,A.; McGuffey,R. A.; Boulay,B. R.; Halline,A. G.; Brown,R. D.; Cotler,S. J.; Jeon,H.; Bui,J. T.; Gaba,R. C.Presurgical transarterial chemoembolization does not increase biliary stricture incidence in orthotopic liver transplant patients Transplantation proceedings 2014 ;46(5):1413-1419
Dahari,H.; Shteingart,S.; Gafanovich,I.; Cotler,S. J.; D'Amato,M.; Pohl,R. T.; Weiss,G.; Ashkenazi,Y. J.; Tichler,T.; Goldin,E.; Lurie,Y.Sustained virological response with intravenous silibinin: individualized IFN-free therapy via real-time modeling of HCV kinetics Liver international : official journal of the International Association for the Study of the Liver 2014 ; :
Kallwitz,E. R.; Daviglus,M. L.; Allison,M. A.; Emory,K. T.; Zhao,L.; Kuniholm,M. H.; Chen,J.; Gouskova,N.; Pirzada,A.; Talavera,G. A.; Youngblood,M. E.; Cotler,S. J.Prevalence of Suspected Non-alcoholic Fatty Liver Disease in Hispanic/Latino Individuals Differs by Heritage Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2014 ; :
Kallwitz,E. R.; Loy,V.; Mettu,P.; Von Roenn,N.; Berkes,J.; Cotler,S. J.Physical activity and metabolic syndrome in liver transplant recipients Liver Transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2013 ; :
Yap,F. Y.; Bui,J. T.; Knuttinen,M. G.; Walzer,N. M.; Cotler,S. J.; Owens,C. A.; Berkes,J. L.; Gaba,R. C.Quantitative morphometric analysis of hepatocellular carcinoma: development of a programmed algorithm and preliminary application Diagnostic and interventional radiology (Ankara, Turkey) 2013 ;19(2):97-105
Guedj,J.; Dahari,H.; Rong,L.; Sansone,N. D.; Nettles,R. E.; Cotler,S. J.; Layden,T. J.; Uprichard,S. L.; Perelson,A. S.Modeling shows that the NS5A inhibitor daclatasvir has two modes of action and yields a shorter estimate of the hepatitis C virus half-life Proceedings of the National Academy of Sciences of the United States of America 2013 ;110(10):3991-3996
Dahari,H.; Cotler,S. J.; Layden,T. J.; Perelson,A. S.Understanding triphasic HCV decline during treatment in the era of IL28B polymorphisms and direct acting antiviral agents via mathematical modeling Journal of Hepatology 2013 ;58(4):840-842
Dahari,H.; Cotler,S. J.Individualized treatment for patients with low HCV load (genotype 1): A viral kinetic approach Hepatology (Baltimore, Md.) 2013 ; :
Gaba,R. C.; Couture,P. M.; Bui,J. T.; Knuttinen,M. G.; Walzer,N. M.; Kallwitz,E. R.; Berkes,J. L.; Cotler,S. J.Prognostic capability of different liver disease scoring systems for prediction of early mortality after transjugular intrahepatic portosystemic shunt creation Journal of vascular and interventional radiology : JVIR 2013 ;24(3):411-20, 420.e1-4; quiz 421
Gaba,R. C.; Omene,B. O.; Podczerwinski,E. S.; Knuttinen,M. G.; Cotler,S. J.; Kallwitz,E. R.; Berkes,J. L.; Walzer,N. M.; Bui,J. T.; Owens,C. A.TIPS for treatment of variceal hemorrhage: clinical outcomes in 128 patients at a single institution over a 12-year period Journal of vascular and interventional radiology : JVIR 2012 ;23(2):227-235
Cotler,S. J.; Cotler,S.; Xie,H.; Luc,B. J.; Layden,T. J.; Wong,S. S.Characterizing hepatitis B stigma in Chinese immigrants Journal of viral hepatitis 2012 ;19(2):147-152
Cotler,S. J.; Cotler,S.; Xie,H.; Luc,B. J.; Layden,T. J.; Wong,S. S.Characterizing hepatitis B stigma in Chinese immigrants Journal of viral hepatitis 2012 ;19(2):147-152
Layden,J. E.; Cotler,S. J.; Grim,S. A.; Fischer,M. J.; Lucey,M. R.; Clark,N. M.Impact of donor and recipient race on survival after hepatitis C-related liver transplantation Transplantation 2012 ;93(4):444-449
Malespin,M.; Wong,S.; Siqueira,F.; Luc,B.; Ravaee,B.; Vainder,C.; Cotler,S. J.Barriers to treatment of hepatitis B in an urban Chinatown community Journal of clinical gastroenterology 2012 ;46(8):e66-70
Layden,J. E.; Cotler,S.; Brown,K. A.; Lucey,M. R.; Te,H. S.; Eswaran,S.; Fimmel,C.; Layden,T. J.; Clark,N. M.Racial differences in fibrosis progression after HCV-related liver transplantation Transplantation 2012 ;94(2):178-184
Tencate,V.; Sainz,B.,Jr; Cotler,S. J.; Uprichard,S. L.Potential treatment options and future research to increase hepatitis C virus treatment response rate Hepatic medicine : evidence and research 2010 ;2010(2):125-145
Bogetti,D.; Jarzembowski,T. M.; Sankary,H. N.; Manzelli,A.; Knight,P. S.; Chejfec,G.; Cotler,S.; Oberholzer,J.; Testa,G.; Benedetti,E.Hepatic ischemia/reperfusion injury can be modulated with thymoglobulin induction therapy. Transplantation proceedings 2005 ;37(1):404-406
Bogetti,D.; Sankary,H. N.; Jarzembowski,T. M.; Manzelli,A.; Knight,P. S.; Thielke,J.; Chejfec,G.; Cotler,S.; Oberholzer,J.; Testa,G.; Benedetti,E.Thymoglobulin induction protects liver allografts from ischemia/reperfusion injury. Clinical transplantation 2005 ;19(4):507-511
Medical School
University of Chicago Pritzker School of Medicine
University of Chicago Medical Center, Internal Medicine: General
Rush-Presbyterian-St. Luke's Medical Center, Internal Medicine: Gastroenterology
University of Washington Medical Center, Internal Medicine: Hepatology
Interests & Hobbies
© 2011 Loyola University Chicago Health Sciences Division. All rights reserved.  &npsp; Privacy Policy   Privacy Policy